Garlic Preventive Effect on Cancer Development
Today, millions of people are living with cancer or have had cancer. The risk of developing most types of cancer can be reduced by changes in a person’s lifestyle or by adopting primary intervention strategies. Often, the sooner a cancer is found and treatment begins, the better are the chances for living for many years. Cancer is a disorder of cell proliferation and it is the leading global cause of death. Cancer research has traditionally focused on allocating bioactive components for the cancer prevention by eliminating cancerous cells and cellular carcinogenesis metabolites. Carcinogenesis is a multistage process that is distinguished with two steps; the first step is called initiation that occurs when cells are exposed to cancer-producing agents, which damage the cell’s deoxynucleic acid. The second step is called promotion which occurs when the cancerous cells divided subsequently, and this post ignition step is characterized by neoplasia and DNA adducts formation. Cancer morbidity and mortality afflicts both genders, and at a global level, there are about 945,000 new cancer cases and 620,000.
- 8.Li X, Meng Y, Xie C, Zhu J, Wang X, Li Y, Geng S, Wu J, Zhong C, Li M. Diallyl trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway. J Cell Biochem. 2017. https://doi.org/10.1002/jcb.26613.
- 17.Zhu X, Jiang X, Li A, Sun Y, Liu Y, Sun X, Feng X, Li S, Zhao Z. S-allylmercaptocysteine suppresses the growth of human gastric cancer xenografts through induction of apoptosis and regulation of MAPK and PI3K/Akt signaling pathways. Biochem Biophys Res Commun. 2017;491(3):821–6.CrossRefPubMedGoogle Scholar
- 19.Xiao D, Pinto JT, Soh JW, Deguchi A, Gundersen GG, Palazzo AF, Yoon JT, Shirin H, Weinstein IB. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. Cancer Res. 2003;63(20):6825–37.PubMedGoogle Scholar
- 20.Park JM, Han YM, Kangwan N, Lee SY, Jung MK, Kim EH, Hahm KB. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histonedeacetylation inhibition. J Gastroenterol Hepatol. 2014;29(Suppl 4):80–92.CrossRefPubMedGoogle Scholar